Vanguard Portfolio Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
Vanguard Portfolio Management's ADMA Position: Q3 2026 in Review
Vanguard Portfolio Management reduced its ADMA Biologics (ADMA) stake by 8.7% in Q3 2026, selling an estimated $8.15M and leaving 9,207,177 shares worth $92.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1513.
Vanguard Portfolio Management first reported a position in ADMA in Q1 2026 and has held it in 3 quarters since. 330 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.
- Vanguard Portfolio Management held 9,207,177 shares of ADMA Biologics worth $92.3M as of Q3 2026.
- Vanguard Portfolio Management sold 881,313 ADMA Biologics shares in Q3 2026, an estimated $8.15M.
- ADMA Biologics made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1513 holding.
- Vanguard Portfolio Management first reported a position in ADMA Biologics in Q1 2026 and has held it in 3 quarters since.
- 330 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.
Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.